Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Inflammatory Bowel Diseases

  Free Subscription


10 Aliment Pharmacol Ther
1 Am J Gastroenterol
1 Am J Surg
3 Clin Exp Immunol
2 Clin Gastroenterol Hepatol
1 Dis Colon Rectum
1 Eur J Gastroenterol Hepatol
2 Gastroenterology
5 Inflamm Bowel Dis
5 J Crohns Colitis
2 PLoS One
1 Scand J Gastroenterol
1 Z Gastroenterol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Aliment Pharmacol Ther

  1. OKABAYASHI S, Kobayashi T
    Editorial: Exploring the influence of diet on later-onset ulcerative colitis-Are eggs and spicy foods the key factors in Asia?
    Aliment Pharmacol Ther. 2024 Apr 21. doi: 10.1111/apt.17983.

  2. URQUHART SA, Fletcher JG, Bruining DH
    Editorial: Foretelling the future-Emerging role of magnetic resonance enterography as a prognostic tool in Crohn's disease.
    Aliment Pharmacol Ther. 2024 Apr 21. doi: 10.1111/apt.17991.

  3. VUIJK SA, Jongsma MME, Hoeven BM, Cozijnsen MA, et al
    Randomised clinical trial: First-line infliximab biosimilar is cost-effective compared to conventional treatment in paediatric Crohn's disease.
    Aliment Pharmacol Ther. 2024 Apr 21. doi: 10.1111/apt.18000.
    PubMed         Abstract available

  4. FERNANDEZ-CLOTET A, Ordas I, Masamunt MC, Caballol B, et al
    Magnetic resonance enterography findings 46 weeks after initiation of biological therapy predict long-term adverse outcomes in Crohn's disease.
    Aliment Pharmacol Ther. 2024 Apr 23. doi: 10.1111/apt.17968.
    PubMed         Abstract available

  5. YIU TH, Ko Y, Pudipeddi A, Natale P, et al
    Meta-analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease.
    Aliment Pharmacol Ther. 2024 Apr 23. doi: 10.1111/apt.18006.
    PubMed         Abstract available

  6. FUKUDA T, Yamazaki H, Miyatani Y, Sawada T, et al
    Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing.
    Aliment Pharmacol Ther. 2024 Apr 23. doi: 10.1111/apt.18013.
    PubMed         Abstract available

  7. SHAH A, Holtmann G
    Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis-associated inflammatory bowel disease?
    Aliment Pharmacol Ther. 2024;59:1290-1291.

  8. DERIKX LAAP, Hoentjen F
    Editorial: Sequencing rescue therapy for acute severe ulcerative colitis-Ready for revision?
    Aliment Pharmacol Ther. 2024;59:1296-1297.

  9. GARCIA MJ, Gisbert JP, Chaparro M
    Editorial: Sequencing rescue therapy for acute severe ulcerative colitis-Ready for revision? Authors' reply.
    Aliment Pharmacol Ther. 2024;59:1298-1299.

  10. SONG S, Wu Z, Lv J, Yu C, et al
    Dietary factors and patterns in relation to risk of later-onset ulcerative colitis in Chinese: A prospective study of 0.5 million people.
    Aliment Pharmacol Ther. 2024 Apr 23. doi: 10.1111/apt.17963.
    PubMed         Abstract available

    Am J Gastroenterol

  11. STIDHAM RW, Enchakalody B, Wang SC, Su GL, et al
    Artificial Intelligence for Quantifying Cumulative Small Bowel Disease Severity on CT-Enterography in Crohn's Disease.
    Am J Gastroenterol. 2024 Apr 25. doi: 10.14309/ajg.0000000000002828.
    PubMed         Abstract available

    Am J Surg

  12. CLEMENT E, Lin W, Shojaei D, Au-Yeung P, et al
    Modified 2-stage IPAA has similar postoperative complication rates and functional outcomes compared to 3-stage IPAA.
    Am J Surg. 2024;231:96-99.
    PubMed         Abstract available

    Clin Exp Immunol

  13. ESLAMIAN G, Jamee M, Momen T, Rohani P, et al
    Genomic Testing Identifies Monogenic Causes in Patients with Very Early-Onset Inflammatory Bowel Disease: A Multi-center Survey in an Iranian Cohort.
    Clin Exp Immunol. 2024 Apr 23:uxae037. doi: 10.1093.
    PubMed         Abstract available

  14. PREUSS B, Frank A, Terjung B, Spengler U, et al
    Autoantibodies to beta tubulin in autoimmune liver diseases-Relation to pANCA and clinical relevance.
    Clin Exp Immunol. 2024;216:146-158.
    PubMed         Abstract available

  15. MAO Z, Betti MJ, Cedeno MA, Pedroza LA, et al
    Clinical and cellular phenotypes resulting from a founder mutation in IL10RB.
    Clin Exp Immunol. 2024;216:113-119.
    PubMed         Abstract available

    Clin Gastroenterol Hepatol

  16. SINGH S, Velayos FS, Rubin DT
    Common Instances of Low-value Care in Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2024;22:923-932.
    PubMed         Abstract available

  17. SOFIA MA, Feuerstein JD, Narramore L, Chachu KA, et al
    White Paper: American Gastroenterological Association Position Statement: The Future of IBD Care in the United States-Removing Barriers and Embracing Opportunities.
    Clin Gastroenterol Hepatol. 2024;22:944-955.
    PubMed         Abstract available

    Dis Colon Rectum

  18. YILMAZ S, Gunter RL, Kanters AE, Rosen DR, et al
    Segmental Colectomy in Ulcerative Colitis.
    Dis Colon Rectum. 2024 Apr 23. doi: 10.1097/DCR.0000000000003311.
    PubMed         Abstract available

    Eur J Gastroenterol Hepatol

  19. YUAN B, Huang P, Yang M, Tang G, et al
    Intestinal ultrasound scan predicts corticosteroid failure and colectomy risk in patients with ulcerative colitis.
    Eur J Gastroenterol Hepatol. 2024 Apr 17. doi: 10.1097/MEG.0000000000002780.
    PubMed         Abstract available


  20. BAMIDELE AO, Mishra SK, Piovezani Ramos G, Hirsova P, et al
    Interleukin 21 Drives a Hypermetabolic State and CD4(+) T-Cell-Associated Pathogenicity in Chronic Intestinal Inflammation.
    Gastroenterology. 2024;166:826-841.
    PubMed         Abstract available

  21. LUJAN R, Buchuk R, Focht G, Yogev D, et al
    Early Initiation of Biologics and Disease Outcomes in Adults and Children With Inflammatory Bowel Diseases: Results From the Epidemiology Group of the Nationwide Israeli Inflammatory Bowel Disease Research Nucleus Cohort.
    Gastroenterology. 2024;166:815-825.
    PubMed         Abstract available

    Inflamm Bowel Dis

  22. KHANNA R, Feagan BG, Zou G, Stitt LW, et al
    Reliability and Responsiveness of Clinical and Endoscopic Outcome Measures in Crohn's Disease.
    Inflamm Bowel Dis. 2024 Apr 25:izae089. doi: 10.1093.
    PubMed         Abstract available

  23. CHIN S, Fox L, Majumdar A, Oliver M, et al
    Pneumocystis jirovecii Pneumonia Complicating Use of Upadacitinib in a Patient With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Case Report.
    Inflamm Bowel Dis. 2024 Apr 24:izae091. doi: 10.1093.

  24. FUKUDA T, Aoki Y, Kiyohara H, Yokoyama A, et al
    Efficacy of Dose Escalation of Oral 5-Aminosalicylic Acid for Ulcerative Colitis With a Mayo Endoscopic Subscore of 1: An Open Label Randomized Controlled Trial.
    Inflamm Bowel Dis. 2024 Apr 24:izae088. doi: 10.1093.
    PubMed         Abstract available

  25. KRUIS W, Bokemeyer B, Jessen P, Hoesl M, et al
    Prospective Evaluation of the Prediction Score for a Mild Course of Crohn's Disease (PreMiCC) in Newly Diagnosed Patients With Crohn's Disease: The PROGNOS Study.
    Inflamm Bowel Dis. 2024 Apr 22:izae086. doi: 10.1093.
    PubMed         Abstract available

  26. DESAI A, Khataniar H, Hashash JG, Farraye FA, et al
    Effectiveness and Safety of Semaglutide for Weight Loss in Patients With Inflammatory Bowel Disease and Obesity.
    Inflamm Bowel Dis. 2024 Apr 20:izae090. doi: 10.1093.
    PubMed         Abstract available

    J Crohns Colitis

  27. CHETWOOD JD, Tran Y, Subramanian S, Smith PJ, et al
    Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    J Crohns Colitis. 2024 Apr 24:jjae059. doi: 10.1093.
    PubMed         Abstract available

  28. OLLECH JE, Yanai H
    Navigating Postoperative Management in Crohn's Disease: Insights from the PORCSE Study.
    J Crohns Colitis. 2024 Apr 20:jjae054. doi: 10.1093.

  29. SCHROEDER MK, Abushamma S, George AT, Ravella B, et al
    TOpCLASS Expert Consensus Classification of Perianal Fistulizing Crohn's Disease: A Real-World Application in a Serial Fistula MRI Cohort.
    J Crohns Colitis. 2024 Apr 20:jjae056. doi: 10.1093.
    PubMed         Abstract available

  30. VIEUJEAN S, Lindsay JO, D'Amico F, Ahuja V, et al
    Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases [IBD]: Real World Results from the International Organization for the study of IBD.
    J Crohns Colitis. 2024;18:548-559.
    PubMed         Abstract available

  31. HINDMARCH DC, Malashanka S, Shows DM, Clarke AS, et al
    Janus Kinase Inhibitors Differentially Inhibit Specific Cytokine Signals in the Mesenteric Lymph Node Cells of Inflammatory Bowel Disease Patients.
    J Crohns Colitis. 2024;18:628-637.
    PubMed         Abstract available

    PLoS One

  32. XU F, Carlson SA, Greenlund KJ
    Understanding primary care providers' attitudes towards preventive screenings to patients with inflammatory bowel disease.
    PLoS One. 2024;19:e0299890.
    PubMed         Abstract available

  33. ALAHDAL H, Almuneef G, Alkhulaifi MM, Aldibasi O, et al
    Gut microbiota composition in patients with Crohn's disease in Saudi Arabia.
    PLoS One. 2024;19:e0299749.
    PubMed         Abstract available

    Scand J Gastroenterol

  34. HAMMOUDI N, Hassid D, Bonnet J, Tran Minh ML, et al
    Infliximab desensitization in patients with inflammatory bowel diseases: a safe therapeutic alternative.
    Scand J Gastroenterol. 2024;59:553-560.
    PubMed         Abstract available

    Z Gastroenterol

  35. STRATMANN K, Hentschel V, Zeuzem S, Blumenstein I, et al
    [Iron supplementation in patients with chronic inflammatory bowel disease: recommendations for a practical approach].
    Z Gastroenterol. 2024 Apr 24. doi: 10.1055/a-2274-1610.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.